Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Aes-103

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
  • M. Safo, G. Kato
  • Hematology/oncology clinics of North America
  • 2014
  • Corpus ID: 9014903
The pathophysiology of sickle cell disease involves the polymerization of sickle hemoglobin in its T state, which develops under… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2014
Highly Cited
2014
In preclinical and early phase pharmacologic trials in sickle cell disease, the percentage of sickled erythrocytes after… 
2014
2014
Background: Under hypoxic conditions, sickle hemoglobin (HbS) polymerizes, causing morphologic distortion (sickling) of red blood… 
Review
2013
Review
2013
Abstract Background Aes-103 (5-hydroxymethylfurfural, 5-HMF) is a putative anti-sickling agent that has undergone pre-clinical… 
2012
2012
Abstract 3210 5-HMF (5-hydroxymethyl-2-furfural; Aes-103) is a breakdown product of glucose that has potent anti-sickling…